Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler

Not Applicable

Not yet recruiting

Conditions: Anterior Cerebral Artery Syndrome
Acute Ischemic Stroke
Cardioembolic Stroke
Congestive Heart Failure
Diabetes
Anterior Cerebral Artery Stroke
Coronary Artery Disease
Vasogenic Cerebral Edema

First Posted Date: 2025-06-10

Last Posted Date: 2025-06-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 100

Registration Number: NCT07013396

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

FearLess in NeuroOncology

Recruiting

Conditions: Primary Malignant Brain Tumor
Glioblastoma (GBM)
Astrocytoma
Oligodendroglioma
Caregiver

First Posted Date: 2025-05-25

Last Posted Date: 2025-06-25

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 112

Registration Number: NCT06989086

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects

Phase 2

Recruiting

Conditions: Opioid Use Disorder
Opioid Use
Insomnia
Orexin Antagonist

Interventions: Drug: Placebo
Drug: Lemborexant 10 MG

First Posted Date: 2025-05-20

Last Posted Date: 2025-06-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 100

Registration Number: NCT06981195

Locations: 🇺🇸
VCU Institute for Drug and Alcohol Studies, Richmond, Virginia, United States

Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation

Phase 1

Not yet recruiting

Conditions: Breast Cancer

Interventions: Drug: Azelaic Acid

First Posted Date: 2025-05-11

Last Posted Date: 2025-05-11

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 33

Registration Number: NCT06966388

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

A Single-session Intervention Adaptation of the Habit Framework for the Prevention of Eating Disorders

Not Applicable

Recruiting

Conditions: Eating Disorder Not Otherwise Specified

First Posted Date: 2025-03-25

Last Posted Date: 2025-04-03

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 160

Registration Number: NCT06861608

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques

Not Applicable

Recruiting

Conditions: Mucosal Erosion
Gingival Recession

First Posted Date: 2025-03-24

Last Posted Date: 2025-04-06

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 42

Registration Number: NCT06892496

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study

Phase 1

Recruiting

Conditions: Statin Adverse Reaction

Interventions: Drug: Low-dose colchicine at 0.5mg daily
Other: Placebo

First Posted Date: 2025-03-13

Last Posted Date: 2025-05-15

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 30

Registration Number: NCT06874192

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Psychobiological Responses Following Exercise and Brain Stimulation

Not Applicable

Recruiting

Conditions: Psychological

First Posted Date: 2025-03-13

Last Posted Date: 2025-04-16

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 29

Registration Number: NCT06874595

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

The Impact of Chronic E-Cigarette Usage on Microvascular Health

Recruiting

Conditions: E-Cig Use

First Posted Date: 2025-03-06

Last Posted Date: 2025-03-11

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 44

Registration Number: NCT06860698

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Phase 2

Recruiting

Conditions: Diffuse Large B-cell Lymphoma
DLBCL - Diffuse Large B Cell Lymphoma

Interventions: Drug: Zanubrutinib

First Posted Date: 2025-02-26

Last Posted Date: 2025-06-02

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 21

Registration Number: NCT06846463

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy